Efficacy and Safety of Firsekibart in the Treatment of Systemic Sclerosis
Efficacy and Safety of Firsekibart in the Treatment of Systemic Sclerosis
Not yet recruiting · NCT07502105 · Registry updated 2026-04-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Firsekibart in the Treatment of Systemic Sclerosis | Skin and Connective Tissue Diseases, connective tissue disorder, skin disorder, systemic sclerosis | Not yet recruiting | Not applicable | 2026-04-20 | NCT07502105 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Tongji Hospital | 276 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Tongji Hospital, Tong ji Medical Colledge | Wuhan | China | 1 |